Skip to main content

Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.

Publication ,  Journal Article
Dottino, JA; Hasselblad, V; Secord, AA; Myers, ER; Chino, J; Havrilesky, LJ
Published in: Obstet Gynecol
October 2016

OBJECTIVE: To estimate the cost-effectiveness of the levonorgestrel intrauterine device (IUD) as an endometrial cancer prevention strategy in obese women. METHODS: A modified Markov model was used to compare IUD placement at age 50 with usual care among women with a body mass index (BMI, kg/m) 40 or greater or BMI 30 or greater. The effects of obesity on incidence and survival were incorporated. The IUD was assumed to confer a 50% reduction in cancer incidence over 5 years. Costs of IUD and cancer care were included. Clinical outcomes were cancer diagnosis and deaths from cancer. Incremental cost-effectiveness ratios were calculated in 2015 U.S. dollars per year of life saved. One-way and two-way sensitivity analyses and Monte Carlo probabilistic analyses were performed. RESULTS: For a 50 year old with BMI 40 or greater, the IUD strategy is costlier and more effective than usual care with an incremental cost-effectiveness ratio of $74,707 per year of life saved. If the protective effect of the levonorgestrel IUD is assumed to be 10 years, the incremental cost-effectiveness ratio decreases to $37,858 per year of life saved. In sensitivity analysis, a levonorgestrel IUD that reduces cancer incidence by at least 68% in women with BMIs of 40 or greater or costs less than $500 is potentially cost-effective. For BMI 30 or greater, the incremental cost-effectiveness ratio of IUD strategy is $137,223 per year of life saved compared with usual care. In Monte Carlo analysis, IUD placement for BMI 40 or greater is cost-effective in 50% of simulations at a willingness-to-pay threshold of $100,000 per year of life saved. CONCLUSION: The levonorgestrel IUD is a potentially cost-effective strategy for prevention of deaths from endometrial cancer in obese women.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Obstet Gynecol

DOI

EISSN

1873-233X

Publication Date

October 2016

Volume

128

Issue

4

Start / End Page

747 / 753

Location

United States

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • Obesity
  • Monte Carlo Method
  • Models, Economic
  • Middle Aged
  • Levonorgestrel
  • Intrauterine Devices, Medicated
  • Humans
  • Female
  • Endometrial Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dottino, J. A., Hasselblad, V., Secord, A. A., Myers, E. R., Chino, J., & Havrilesky, L. J. (2016). Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. Obstet Gynecol, 128(4), 747–753. https://doi.org/10.1097/AOG.0000000000001616
Dottino, Joseph A., Vic Hasselblad, Angeles Alvarez Secord, Evan R. Myers, Junzo Chino, and Laura J. Havrilesky. “Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.Obstet Gynecol 128, no. 4 (October 2016): 747–53. https://doi.org/10.1097/AOG.0000000000001616.
Dottino JA, Hasselblad V, Secord AA, Myers ER, Chino J, Havrilesky LJ. Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. Obstet Gynecol. 2016 Oct;128(4):747–53.
Dottino, Joseph A., et al. “Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.Obstet Gynecol, vol. 128, no. 4, Oct. 2016, pp. 747–53. Pubmed, doi:10.1097/AOG.0000000000001616.
Dottino JA, Hasselblad V, Secord AA, Myers ER, Chino J, Havrilesky LJ. Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. Obstet Gynecol. 2016 Oct;128(4):747–753.

Published In

Obstet Gynecol

DOI

EISSN

1873-233X

Publication Date

October 2016

Volume

128

Issue

4

Start / End Page

747 / 753

Location

United States

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • Obesity
  • Monte Carlo Method
  • Models, Economic
  • Middle Aged
  • Levonorgestrel
  • Intrauterine Devices, Medicated
  • Humans
  • Female
  • Endometrial Neoplasms